Skip to content

Vascular Access and Intraosseus

Impact of Vascular Access Route and Drug Presentation on Epinephrine Administration Time: A Pilot Study in Clinical Simulation

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07471555
Acronym
IO_nursing
Enrollment
52
Registered
2026-03-13
Start date
2026-04-02
Completion date
2026-12-03
Last updated
2026-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To Compare the Time Required to Administer 1 mg of Epinephrine, as Well as the Total Procedure

Keywords

Vascular Access Devices, simulation

Brief summary

Rapid administration of epinephrine is an essential component of advanced life support during cardiac arrest. Peripheral intravenous (IV) access is commonly used for drug delivery, while intraosseous (IO) access is an alternative when IV access is not readily available. In addition, epinephrine may be administered using different drug presentations, such as ampoules or prefilled syringes, which may influence procedural workflow during resuscitation.

Detailed description

Out-of-hospital cardiac arrest (OHCA) is a time-critical emergency that requires rapid and coordinated interventions by healthcare professionals. Advanced life support protocols emphasize high-quality cardiopulmonary resuscitation, minimization of interruptions, and timely administration of vasoactive medications such as epinephrine in non-shockable rhythms. Peripheral intravenous (IV) access is frequently used as the initial route for drug administration during cardiac arrest, while intraosseous (IO) access is incorporated into resuscitation algorithms as an alternative when IV access is difficult or delayed. The practical implementation of these access routes may vary depending on operator experience, technical complexity, and clinical context. In addition to the choice of vascular access, the presentation of emergency medications may affect procedural performance during resuscitation. Epinephrine can be prepared from ampoules or administered using prefilled syringes, each involving different handling steps during emergency care. Evaluating procedural timing across these variables in a controlled environment may provide information relevant to training and workflow optimization. The purpose of this study is to evaluate the time required to administer 1 mg of epinephrine and the total procedure time according to the vascular access route (IV versus IO) and the drug presentation (ampoule versus prefilled syringe) in a simulated cardiac arrest setting. Participants will be fourth-year nursing students enrolled during the 2023-2024 academic year. Participation will be voluntary. All participants will receive standardized theoretical and practical training before taking part in the simulation scenarios. The intervention consists of a 4-hour theoretical-practical training session. The theoretical component will cover the principles, indications, and procedural steps of peripheral intravenous and intraosseous access. The practical component will involve supervised hands-on training in a simulation laboratory. Peripheral IV access will be practiced using an adult intravenous training arm (Multi-venous IV training arm adult, Laerdal®). Intraosseous access will be practiced using porcine tibias as an anatomical model. Following training, participants will perform simulated epinephrine administration scenarios according to their randomized allocation. The primary variable recorded will be the time from the start of the procedure to the administration of 1 mg of epinephrine. Additional procedural timing variables will be collected to characterize the drug administration process under standardized simulation conditions.

Interventions

DEVICEEpinephrine Ampoule (Manual Preparation)

Standard 1 mg/mL glass ampoule requiring manual aspiration with a needle and syringe before administration.

DEVICEEpinephrine Prefilled Syringe (Ready-to-use)

Ready-to-use 1 mg/10 mL prefilled syringe system for immediate administration.

OTHERIntravenous (IV) Access

Peripheral venous cannulation procedure.

DEVICEIntraosseous (IO) Access Device

Manual or powered intraosseous drill/needle for vascular access.

Sponsors

University of Valencia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 4th year Nursing students

Exclusion criteria

* 1-2-3 th year Nursing students

Design outcomes

Primary

MeasureTime frameDescription
Total Time for Epinephrine Administration.During the simulation procedure (Day 1)The interval of time (in seconds) from the instruction to begin the procedure until the complete administration of 1 mg of epinephrine into the simulation device.

Secondary

MeasureTime frameDescription
Time to Successful Vascular Access (Cannulation Time)During the simulation procedure (Day 1)The interval of time (in seconds) from the instruction to begin the procedure until successful vascular access (cannulation) is achieved in the simulation model.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 30, 2026